H6H
VIVO

Hightower 6M Holding’s Meridian Bioscience Inc VIVO Stock Holding History

Hightower 6M Holding’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$373K Buy
11,817
+3,864
+49% +$125K 0.03% 148
2022
Q2 		$242K Sell
7,953
-3
-0% -$81 0.02% 212
2022
Q1 		$207K Buy
+7,956
New +$189K 0.02% 351

Other funds holding VIVO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hightower 6M Holding's VIVO Position: Q3 2022 in Review

Hightower 6M Holding increased its Meridian Bioscience Inc (VIVO) stake by 49% in Q3 2022, buying an estimated $125K and bringing the position to 11,817 shares worth $373K. The position accounts for 0.03% of the portfolio, ranked #148.

Hightower 6M Holding first reported a position in VIVO in Q1 2022 and has held it in 3 quarters since. 203 funds tracked by Wall St. Rank hold VIVO as of Q3 2022.

  • Hightower 6M Holding held 11,817 shares of Meridian Bioscience Inc worth $373K as of Q3 2022.
  • Hightower 6M Holding bought 3,864 Meridian Bioscience Inc shares in Q3 2022, an estimated $125K.
  • Meridian Bioscience Inc made up 0.03% of Hightower 6M Holding's portfolio in Q3 2022, its #148 holding.
  • Hightower 6M Holding first reported a position in Meridian Bioscience Inc in Q1 2022 and has held it in 3 quarters since.
  • 203 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2022.

Based on Hightower 6M Holding's 13F filing for Q3 2022, filed 25 Oct 2022.